Lysosomal Storage Disease and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Lysosomal Storage Disease (LSD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lysosomal Storage Disease (LSD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lysosomal Storage Disease (LSD) Overall Market Size
2.1 Global Lysosomal Storage Disease (LSD) Market Size: 2022 VS 2030
2.2 Global Lysosomal Storage Disease (LSD) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lysosomal Storage Disease (LSD) Players in Global Market
3.2 Top Global Lysosomal Storage Disease (LSD) Companies Ranked by Revenue
3.3 Global Lysosomal Storage Disease (LSD) Revenue by Companies
3.4 Top 3 and Top 5 Lysosomal Storage Disease (LSD) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lysosomal Storage Disease (LSD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Players in Global Market
3.6.1 List of Global Tier 1 Lysosomal Storage Disease (LSD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lysosomal Storage Disease (LSD) Market Size Markets, 2022 & 2030
4.1.2 Lipid Metabolism Disorder
4.1.3 Glycoprotein Metabolism Disorder
4.2 By Type - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
4.2.1 By Type - Global Lysosomal Storage Disease (LSD) Revenue, 2018-2023
4.2.2 By Type - Global Lysosomal Storage Disease (LSD) Revenue, 2024-2030
4.2.3 By Type - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lysosomal Storage Disease (LSD) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
5.2.1 By Application - Global Lysosomal Storage Disease (LSD) Revenue, 2018-2023
5.2.2 By Application - Global Lysosomal Storage Disease (LSD) Revenue, 2024-2030
5.2.3 By Application - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Lysosomal Storage Disease (LSD) Market Size, 2022 & 2030
6.2 By Region - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
6.2.1 By Region - Global Lysosomal Storage Disease (LSD) Revenue, 2018-2023
6.2.2 By Region - Global Lysosomal Storage Disease (LSD) Revenue, 2024-2030
6.2.3 By Region - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Lysosomal Storage Disease (LSD) Revenue, 2018-2030
6.3.2 US Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.3.3 Canada Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.3.4 Mexico Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Lysosomal Storage Disease (LSD) Revenue, 2018-2030
6.4.2 Germany Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.3 France Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.4 U.K. Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.5 Italy Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.6 Russia Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.7 Nordic Countries Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.4.8 Benelux Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Lysosomal Storage Disease (LSD) Revenue, 2018-2030
6.5.2 China Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.5.3 Japan Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.5.4 South Korea Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.5.5 Southeast Asia Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.5.6 India Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Lysosomal Storage Disease (LSD) Revenue, 2018-2030
6.6.2 Brazil Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.6.3 Argentina Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, 2018-2030
6.7.2 Turkey Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.7.3 Israel Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.7.4 Saudi Arabia Lysosomal Storage Disease (LSD) Market Size, 2018-2030
6.7.5 UAE Lysosomal Storage Disease (LSD) Market Size, 2018-2030
7 Lysosomal Storage Disease (LSD) Companies Profiles
7.1 Actelion Pharmaceuticals
7.1.1 Actelion Pharmaceuticals Company Summary
7.1.2 Actelion Pharmaceuticals Business Overview
7.1.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
7.1.4 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.1.5 Actelion Pharmaceuticals Key News & Latest Developments
7.2 Amicus Therapeutics
7.2.1 Amicus Therapeutics Company Summary
7.2.2 Amicus Therapeutics Business Overview
7.2.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Major Product Offerings
7.2.4 Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.2.5 Amicus Therapeutics Key News & Latest Developments
7.3 Arena Pharmaceuticals
7.3.1 Arena Pharmaceuticals Company Summary
7.3.2 Arena Pharmaceuticals Business Overview
7.3.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
7.3.4 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.3.5 Arena Pharmaceuticals Key News & Latest Developments
7.4 Astellas Pharma
7.4.1 Astellas Pharma Company Summary
7.4.2 Astellas Pharma Business Overview
7.4.3 Astellas Pharma Lysosomal Storage Disease (LSD) Major Product Offerings
7.4.4 Astellas Pharma Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma Key News & Latest Developments
7.5 Astrazeneca
7.5.1 Astrazeneca Company Summary
7.5.2 Astrazeneca Business Overview
7.5.3 Astrazeneca Lysosomal Storage Disease (LSD) Major Product Offerings
7.5.4 Astrazeneca Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.5.5 Astrazeneca Key News & Latest Developments
7.6 Biomarin Pharmaceutical
7.6.1 Biomarin Pharmaceutical Company Summary
7.6.2 Biomarin Pharmaceutical Business Overview
7.6.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Major Product Offerings
7.6.4 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.6.5 Biomarin Pharmaceutical Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Lysosomal Storage Disease (LSD) Major Product Offerings
7.7.4 Eli Lilly Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Lexicon Pharmaceuticals
7.8.1 Lexicon Pharmaceuticals Company Summary
7.8.2 Lexicon Pharmaceuticals Business Overview
7.8.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
7.8.4 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.8.5 Lexicon Pharmaceuticals Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Major Product Offerings
7.9.4 Novo Nordisk Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Lysosomal Storage Disease (LSD) Major Product Offerings
7.10.4 Merck Lysosomal Storage Disease (LSD) Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Lysosomal Storage Disease (LSD) Market Opportunities & Trends in Global Market
Table 2. Lysosomal Storage Disease (LSD) Market Drivers in Global Market
Table 3. Lysosomal Storage Disease (LSD) Market Restraints in Global Market
Table 4. Key Players of Lysosomal Storage Disease (LSD) in Global Market
Table 5. Top Lysosomal Storage Disease (LSD) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Lysosomal Storage Disease (LSD) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Lysosomal Storage Disease (LSD) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Lysosomal Storage Disease (LSD) Product Type
Table 9. List of Global Tier 1 Lysosomal Storage Disease (LSD) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Lysosomal Storage Disease (LSD) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Lysosomal Storage Disease (LSD) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2024-2030
Table 30. Actelion Pharmaceuticals Company Summary
Table 31. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 32. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 33. Actelion Pharmaceuticals Key News & Latest Developments
Table 34. Amicus Therapeutics Company Summary
Table 35. Amicus Therapeutics Lysosomal Storage Disease (LSD) Product Offerings
Table 36. Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 37. Amicus Therapeutics Key News & Latest Developments
Table 38. Arena Pharmaceuticals Company Summary
Table 39. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 40. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 41. Arena Pharmaceuticals Key News & Latest Developments
Table 42. Astellas Pharma Company Summary
Table 43. Astellas Pharma Lysosomal Storage Disease (LSD) Product Offerings
Table 44. Astellas Pharma Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 45. Astellas Pharma Key News & Latest Developments
Table 46. Astrazeneca Company Summary
Table 47. Astrazeneca Lysosomal Storage Disease (LSD) Product Offerings
Table 48. Astrazeneca Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 49. Astrazeneca Key News & Latest Developments
Table 50. Biomarin Pharmaceutical Company Summary
Table 51. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product Offerings
Table 52. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 53. Biomarin Pharmaceutical Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Lysosomal Storage Disease (LSD) Product Offerings
Table 56. Eli Lilly Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Lexicon Pharmaceuticals Company Summary
Table 59. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 60. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 61. Lexicon Pharmaceuticals Key News & Latest Developments
Table 62. Novo Nordisk Company Summary
Table 63. Novo Nordisk Lysosomal Storage Disease (LSD) Product Offerings
Table 64. Novo Nordisk Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 65. Novo Nordisk Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Lysosomal Storage Disease (LSD) Product Offerings
Table 68. Merck Lysosomal Storage Disease (LSD) Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
List of Figures
Figure 1. Lysosomal Storage Disease (LSD) Segment by Type in 2022
Figure 2. Lysosomal Storage Disease (LSD) Segment by Application in 2022
Figure 3. Global Lysosomal Storage Disease (LSD) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lysosomal Storage Disease (LSD) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Lysosomal Storage Disease (LSD) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lysosomal Storage Disease (LSD) Revenue in 2022
Figure 8. By Type - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 16. US Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 20. Germany Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 21. France Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 28. China Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 32. India Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 34. Brazil Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue Market Share, 2018-2030
Figure 37. Turkey Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2018-2030
Figure 41. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astellas Pharma Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Astrazeneca Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novo Nordisk Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
